Loading company…
Montpellier company using digital twin and AI technology to improve treatment of brain aneurysms in neurovascular procedures.
Founded in 2014 in France, Sim&Cure, SA is headquartered in Montpellier and focuses on brain aneurysm treatment, using digital twin and AI tools that support endovascular procedures. Clients include hospitals, clinics and medtech companies, with revenue from direct sales and software subscriptions. On November 28, 2025, it completed a EUR 2.3 mn Series A round led by Elaia Partners. Mathieu Sanchez is founder and CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in